TY - JOUR
T1 - Dengue fever in humanized NOD/SCID mice
AU - Bente, Dennis A.
AU - Melkus, Michael W.
AU - Garcia, J. Victor
AU - Rico-Hesse, Rebeca
PY - 2005/11
Y1 - 2005/11
N2 - The increased transmission and geographic spread of dengue fever (DF) and its more severe presentation, dengue hemorrhagic fever (DHF), make it the most important mosquito-borne viral disease of humans (50 to 100 million infections/year) (World Health Organization, Fact sheet 117, 2002). There are no vaccines or treatment for DF or DHF because there are no animal or other models of human disease; even higher primates do not show symptoms after infection (W. F. Scherer, P. K. Russell, L. Rosen, J. Casals, and R. W. Dickerman, Am. J. Trop. Med. Hyg. 27:590-599, 1978). We demonstrate that nonobese diabetic/severely compromised immunodeficient (NOD/SCID) mice xenografted with human CD34+ cells develop clinical signs of DF as in humans (fever, rash, and thrombocytopenia), when infected in a manner mimicking mosquito transmission (dose and mode). These results suggest this is a valuable model with which to study pathogenesis and test antidengue products.
AB - The increased transmission and geographic spread of dengue fever (DF) and its more severe presentation, dengue hemorrhagic fever (DHF), make it the most important mosquito-borne viral disease of humans (50 to 100 million infections/year) (World Health Organization, Fact sheet 117, 2002). There are no vaccines or treatment for DF or DHF because there are no animal or other models of human disease; even higher primates do not show symptoms after infection (W. F. Scherer, P. K. Russell, L. Rosen, J. Casals, and R. W. Dickerman, Am. J. Trop. Med. Hyg. 27:590-599, 1978). We demonstrate that nonobese diabetic/severely compromised immunodeficient (NOD/SCID) mice xenografted with human CD34+ cells develop clinical signs of DF as in humans (fever, rash, and thrombocytopenia), when infected in a manner mimicking mosquito transmission (dose and mode). These results suggest this is a valuable model with which to study pathogenesis and test antidengue products.
UR - http://www.scopus.com/inward/record.url?scp=27144556922&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27144556922&partnerID=8YFLogxK
U2 - 10.1128/JVI.79.21.13797-13799.2005
DO - 10.1128/JVI.79.21.13797-13799.2005
M3 - Article
C2 - 16227299
AN - SCOPUS:27144556922
SN - 0022-538X
VL - 79
SP - 13797
EP - 13799
JO - Journal of virology
JF - Journal of virology
IS - 21
ER -